EDIT vs PCG · rev $32.3M vs P/E 13, $37.68B cap
Editas Medicine Inc (EDIT) versus PG&E Corp (PCG) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
PCG does not have a complete income-statement cache yet.
EDIT currently screens at market cap $375.2M. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
Not investment advice. Open the EDIT and PCG stock pages for the full models.
Not investment advice.